A specialty chemicals company that earns revenue from a single reported segment called Nutrition-Chemical Industries, supplying chemicals used in nutrition applications. FY26 revenue was Rs 29.61 cr, net profit was Rs 2.71 cr, and EBITDA margin was 12.96%. Raw materials dominate the cost structure at 77.9% of revenue, with employee costs at 4% and other operating expenses at 7.3%, while depreciation is barely 0.2% of revenue and capex is 0% of revenue, indicating a low fixed-asset, trading-leaning profile. The Nutrition-Chemical Industries segment accounted for 100% of segment revenue in the YTD period ending September 2023, generating Rs 8.27 cr in that period. The company is setting up a 75%-owned subsidiary, Oleo Biosciences Private Limited, in Bangalore, Karnataka, which will manufacture oleo chemicals (specialty chemicals) and is currently installing a pilot plant and laboratory equipment, with commercial production expected to begin in FY26-27 and FY27-28. The board has approved an investment of up to Rs 2.25 crore in this subsidiary. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Nutrition-Chemical Industries (100%). Small, single-segment specialty chemicals business with a low fixed-asset, materials-heavy cost structure
| ₹ crore · consolidated | FY26 |
|---|---|
| Revenue | 30 |
| EBITDA (ex other income) | 3 |
| margin % | 10.7 |
| Owners' profit | 0 |
| EPS, as reported (₹) | 9.03 |
| ROE % · ROCE % | 27.4 · 37.8 |
| Debt / equity (x) | 0.00 |
| Cash from operations | 4 |
| Capex | 0 |
| ₹ crore | Q4 FY26 | Q1 FY27 |
|---|---|---|
| Revenue | 10 | 9 |
| Profit before tax | 2 | 1 |
| Net profit | 1 | 1 |
| EPS (₹) | 3.67 | 3.14 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| PIDILITE INDUSTRIES LTD | 1,59,479 | 60.2 | 14.43 | 42.3 | 22.4 | 28.0 | 14.9 | 28.6 |
| SRF LTD | 73,583 | 34.0 | 5.24 | 22.7 | 13.1 | 13.1 | 13.4 | 25.2 |
| GUJARAT FLUOROCHEM LTD | 52,514 | 85.7 | 6.64 | 41.5 | 7.3 | 8.7 | 13.5 | 27.7 |
| NAVIN FLUORINE INT. LTD | 43,836 | 55.4 | 11.03 | 39.5 | 16.7 | 16.4 | 23.0 | 37.5 |
| AETHER INDUSTRIES LIMITED | 22,229 | 94.3 | 9.05 | 60.4 | 8.9 | 11.4 | — | 33.8 |
| DEEPAK NITRITE LTD | 21,769 | 27.8 | 3.71 | 22.4 | 9.4 | 10.2 | 12.6 | 21.5 |
| ATUL LTD | 18,401 | 23.1 | 2.92 | 14.9 | 10.9 | 13.3 | 10.9 | 23.1 |
| AARTI INDUSTRIES LTD | 17,846 | 33.6 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 8 Sept 2026 · Crestchem appoints Compliance Officer and Assistant Company Secretary | management changes | medium | — | — |
| 3 Sept 2026 · Board meeting on Sep 8 to appoint Assistant Company Secretary and Compliance Officer | management changes | low | — | — |
| 14 Aug 2026 · Crestchem files Q1 FY26 results newspaper ad with BSE | compliance | minimal | — | — |
| 12 Aug 2026 · Crestchem Q1 FY27 results: Revenue up 82%, PAT jumps 182% YoY | results | high | — | — |
| 8 Aug 2026 · 34th AGM held via video conferencing; voting results awaited | board shareholder meetings | low | — | — |
| 7 Aug 2026 · All 8 AGM resolutions passed unanimously; Rs 1.50 dividend declared | compliance | minimal | — | — |
| 7 Aug 2026 · Board Meeting on Aug 12, 2026 to Consider Q1 FY26 Results | board shareholder meetings | low | — | — |
| 6 Aug 2026 · 34th AGM of Crestchem held via video conferencing on August 6, 2026 | board shareholder meetings | low | — | — |
| 4 Aug 2026 · BSE imposes 1.06 lakh fine on Crestchem for late cash flow filing | regulatory legal | high | — | — |
| 16 Jul 2026 · Record date fixed for 15% dividend (Rs 1.50 per share) | corporate actions | high | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| 3.00 |
| 18.8 |
| 7.0 |
| 4.4 |
| 13.0 |
| 16.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 20.9 | 23.4 | 45 of 103 | 57% |
| P/B | 4.3 | 2.9 | 70 of 99 | 30% |
| ROCE | 37.7 | 10.3 | 4 of 108 | 97% |
| ROE | 27.4 | 8.1 | 4 of 101 | 97% |
| Debt / Equity | 0.0 | 0.2 | 3 of 101 | 84% |
| EBITDA margin | 14.4 | 15.5 | 53 of 99 | 47% |
| Market cap | 43 | 732 | 93 of 107 | 13% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
